Pfizer
Jason O'Meara is currently the VP of Enterprise Data & Solutions Architecture at Pfizer. Prior to joining Pfizer in March 2019, Jason was the Senior Director of Architecture at Quest Diagnostics from March 2004 to March 2019. In this role, Jason was responsible for overseeing the architectural aspects of Quest Diagnostics' healthcare connectivity and enterprise data & analytics solution architectures. Jason led a team of architects in the creation of business solutions that leveraged a number of technologies, including healthcare interoperability & data exchange standards (HL7v2, FHIR, SMART, etc.), blockchain, bioinformatics, cloud-native architectures, microservices & responsive user experiences, Chatbots & NLP, master data management, data warehousing & big data, data visualization & business intelligence, and AI and advanced analytics. Jason also supported architectural aspects of M&A due diligence.
Before Quest Diagnostics, Jason worked as a Senior Consultant in Information Technology at Cap Gemini Ernst & Young Consulting from August 2000 to March 2004.
Jason O'Meara has a Masters in Health Policy and Administration from the University of North Carolina at Chapel Hill and a BSE in Electrical and Computer Engineering from Duke University.
This person is not in any offices
Pfizer
614 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.